The acquisition will help accelerate Aspirion’s investment in intelligent automation to advance operational effectiveness, recovery yield and pace of collections for its clients, according to a Sept. 12 Aspirion news release.
Infinia ML will operate as Aspirion’s research and development engine, “focusing on leap-ahead AI capabilities to drive improved financial performance for healthcare providers,” according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
